Inventiva S.A.
Status: Publicly traded
Direct answer
Inventiva S.A. is publicly traded on PAR under the ticker IVA.PA.
Inventiva S.A. is a biopharmaceutical firm currently in the clinical development phase, specializing in creating orally administered small molecule treatments for conditions such as non-alcoholic steatohepatitis (NASH), mucopolysaccharidoses (MPS), and various other ailments. Their primary drug candidate, Lanifibranor, has successfully concluded Phase IIb clinical trials for the management of NASH. Furthermore, the...
Can you invest in Inventiva S.A.?
Yes. Inventiva S.A. trades publicly on PAR as IVA.PA.
View deeper analysis
View detailed research on MarketSnap, including financials, valuation tools, and analyst context.
Open research for Inventiva S.A.
Detailed equity research is provided by MarketSnap.